Topic: Challenging questions at the borderline of thyroid cancer surgery and follow up
A joint session of European Thyroid Association-Cancer Research Network
and European Society of Endocrine Surgeons
Chair: Ulla Feldt-Rasmussen, Henning Dralle
| 8:00 |
Registration and coffee | |||
| 8.30 |
Presidential Welcome address: Presidents of ETA-CRN and ESES |
|||
| 8:45 |
Wellcome Adress of Rector of Collegium Medicum of Jagiellonian University | |||
| 9:00 |
Total thyroidectomy for benign thyroid disease improves outcomes of treatment for incidentally diagnosed thyroid cancer |
M.Barczyński |
(Kraków,Poland) |
|
| 9:25 |
Discussion | |||
| 9:40 | What to do when a total thyroidectomy has not been performed at initial surgery and in which patients? | F. Borson-Chazot | (Lyon, France) | |
| 10:05 | Discussion | |||
| 10:20 | Is it time to base therapeutic decision on the BRAF status of thyroid tumors? |
P.Miccoli |
(Pisa,Italy) |
|
| 10:45 | Discussion |
|||
| 11:00 |
Coffee break |
|||
| 11:30 | PET-CT and thyroid nodule |
S.Leboulleux |
(Paris,France) | |
| 11:55 | Discussion | |||
| 12:10 |
Medullary thyroid cancer: cut-off for surgical intervention in postoperative hypercalcitoninaemia |
H.Dralle |
(Halle,Germany) | |
| 12:35 | Discussion |
|||
| 12:50 |
Is it time to use of tyrosine kinase inhibitors in microdisseminated medullary thyroid cancer? |
M.Schlumberger |
(Paris,France) | |
| 13:15 | Discussion | |||
| 13:30 | Lunch | |||
| 14:00 |
ETA-CRN General Assembly | |||
For further information, please contact Secretary of ETA-CRN:
Barbara Jarzab - bjarzab@io.gliwice.pl or eta-crn@io.gliwice.pl
